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MicroRNAs (miRNAs) are posttranscriptional modu-
lators of gene expression and play an important
role in many developmental processes. We report
here that expression of microRNA-145 (miR-145) is
low in self-renewing human embryonic stem cells
(hESCs) but highly upregulated during differentia-
tion. We identify the pluripotency factors OCT4,
SOX2, and KLF4 as direct targets of miR-145 and
show that endogenous miR-145 represses the 30
untranslated regions of OCT4, SOX2, and KLF4.
Increased miR-145 expression inhibits hESC self-
renewal, represses expression of pluripotency
genes, and induces lineage-restricted differentiation.
Loss of miR-145 impairs differentiation and elevates
OCT4, SOX2, and KLF4. Furthermore, we find
that the miR-145 promoter is bound and repressed
by OCT4 in hESCs. This work reveals a direct link
between the core reprogramming factors and
miR-145 and uncovers a double-negative feedback
loop involving OCT4, SOX2, KLF4, and miR-145.
INTRODUCTION
Embryonic stem cells (ESCs) are valuable resources for clinical
therapies because of their unlimited self-renewal ability and
potential to generate any differentiated cell type (pluripotency).
The self-renewal and pluripotency properties are regulated by
an array of protein-coding genes, such as transcription factors
and chromatin remodeling enzymes, in a core regulatory circuitry
(Boyer et al., 2005; Jaenisch and Young, 2008). This circuitry
includes OCT4, SOX2, and KLF4, which form self-regulatory
networks and control a wide range of downstream genes (Boyer
et al., 2005; Jiang et al., 2008). Extensive studies have indicated
that OCT4 (Niwa et al., 2000; Scholer et al., 1990; Zaehres et al.,
2005), SOX2 (Avilion et al., 2003; Fong et al., 2008), and KLF4
(Ivey et al., 2008; Nakatake et al., 2006) are required for ESC
self-renewal and pluripotency. The overexpression of OCT4,
SOX2, and KLF4 along with others, such as NANOG, C-MYC,or LIN28, can reprogram or dedifferentiate somatic cells into
induced pluripotent stem cells (iPSCs) in both mice (Nakagawa
et al., 2008; Takahashi and Yamanaka, 2006; Wernig et al.,
2007) and human (Park et al., 2008; Takahashi et al., 2007; Yu
et al., 2007). In addition to protein-coding genes, a group of non-
codingmicroRNA (miRNA) genes are connected to the transcrip-
tional regulatory circuitry of ESCs (Marson et al., 2008). However,
relatively little is known about howmiRNAs epigenetically modu-
late ESC self-renewal and pluripotency.
miRNAs bind to partially complementary target sites in
messenger RNA (mRNA) 30 untranslated regions (UTRs), which
results in degradation of the target mRNAs, or translational
repression of the encoded proteins (Bartel, 2004). In general,
one gene can be repressed by multiple miRNAs and one miRNA
may repress multiple target genes, which results in the formation
of complex regulatory feedback networks. In a wide variety of
developmental processes, miRNAs fine tune or restrict cellular
identities by targeting important transcription factors or key
pathways (Stefani and Slack, 2008). The cell type-specific
expression signature of miRNAs in ESCs has been used
successfully to distinguish ESCs from differentiated cell types
(Wang et al., 2008). Several groups reported genome-wide
miRNA expression profiles using various platforms (Houbaviy
et al., 2003; Laurent et al., 2008; Mineno et al., 2006; Suh
et al., 2004). More than 100 miRNAs are differentially expressed
in human embryonic stem cells (hESCs) and the differentiated
embryoid bodies (EBs) (Morin et al., 2008), but the genes tar-
geted by most of these miRNAs are unknown. The characteriza-
tion of the miRNA pathways and their underlying molecular
mechanisms is of great importance to the understanding of
ESC self-renewal and pluripotency.
The requirement of miRNAs in maintenance of ESC popula-
tions and pluripotency was initially demonstrated by genetic
studies. Murine ESCs with genetic deletion of key miRNA pro-
cessing enzymes Dicer (Kanellopoulou et al., 2005; Murchison
et al., 2005) or DGCR8 (Wang et al., 2007) lose their pluripotency
and show defective differentiation. Dicer-deficient mutant ESCs
can be partially rescued by the miR-290 cluster miRNAs that
regulate Rbl2-dependent DNA methylation to downregulate
Oct4 indirectly (Benetti et al., 2008; Sinkkonen et al., 2008).
However, miR-290 decreases during ESC differentiation, when
Oct4 needs to be switched off, which makes it less likely to beCell 137, 647–658, May 15, 2009 ª2009 Elsevier Inc. 647
a dominant player in the differentiation process. On the other
hand, mutant DGCR8 ESCs do not fully downregulate pluripo-
tencymarkers such asOct4, Rex1, Sox2, andNanog in response
to differentiation (Wang et al., 2007). Therefore, it remains
unclear what miRNAs may be involved in the direct repression
of pluripotency markers. The study of the functions of miRNAs
in ESCs is still in an early stage, and the direct roles of miRNAs
in downregulating pluripotency genes are yet to be investigated.
Here, we set out to investigate the roles of miRNA in the direct
repressionof pluripotencygenes in hESCs.Wehypothesized that
the 30 UTRsof pluripotencygenesmaybe targeted for downregu-
lation by miRNAs in hESCs to allow attenuation of the self-
renewal program. We searched for miRNAs that have increased
expression levels during ESC differentiation and are predicted
to target hESC transcription factors. By expression analysis
and computational predictions, we identified miR-145 as a
temporally regulatedmiRNAduring hESCdifferentiation and vali-
dated that it can target 30 UTRs ofOCT4, SOX2, andKLF4 in luci-
ferase assays in both HeLa cells and hESCs. By gain-of-function
and loss-of function approaches, we showed that the endoge-
nous levels of OCT4, SOX2, and KLF4 are controlled posttran-
scriptionally by miR-145 in hESCs. Contrary to the decrease of
the pluripotency factors during differentiation, miR-145 level
was relatively low in hESCs and increased during differentiation.
We found that ectopic miR-145 expression significantly disrupts
the maintenance of hESCs in the self-renewal state. The function
of miR-145 was further investigated during hESC differentiation,
and we revealed that miR-145 is necessary and sufficient to
modulate the differentiation progression through the OCT4/
SOX2 pathway. In addition, the promoter of miR-145 was
repressed by OCT4 in hESCs. In brief, miR-145 is connected to
pluripotency network in a double-negative feedback loop. We
uncovered a direct link between a miRNA and the core pluripo-
tency factors OCT4, SOX2, and KLF4 and demonstrated that
miR-145 repressespluripotencyandcontrols ESCdifferentiation.
RESULTS
Identification of miR-145 as a Temporally Regulated
miRNA during hESC Differentiation
To identify human miRNAs that display temporal expression
regulation, we compared expression profiles of 466 miRNAs
between undifferentiated hESC line H9 and differentiated EBs
using the Taqman real-time multiplex RT-PCRmethod, a reliable
technique to quantify the levels of mature miRNAs (Kye et al.,
2007). The quality of the hESC culture was confirmed by immu-
nostaining and karyotype analysis. hESCs expressed stem cell
markers OCT4, NANOG, and SOX2, and EB differentiation
produced precursor cells of the three germ layers (Figure S1
available online). Our miRNA expression analysis yielded results
consistent with previous reports: two clusters of miRNAs,
miR-302 and miR-371/372/373, were ESC specific (Laurent
et al., 2008; Morin et al., 2008; Suh et al., 2004) (Figure S2).
From the expression analysis, we found that miR-145 was
expressed at relatively low level in undifferentiated hESCs, but
was significantly upregulated in EBs (Figures 1A and 1B). The
temporal upregulation of miR-145 was also observed in BMP4-
induced hESC differentiation in a time course consistent with648 Cell 137, 647–658, May 15, 2009 ª2009 Elsevier Inc.the downregulation of OCT4 expression (Figure S3). miR-145,
identified in mice (Lagos-Quintana et al., 2001) and later in
human (Michael et al., 2003), contains a unique seed sequence
that is conserved in Xenopus, zebrafish, and various mammals.
Human miR-145 is enriched in germline and mesoderm-derived
tissues, such as uterus, ovary, testis, prostate, spleen, and heart
(Landgraf et al., 2007). We focused onmiR-145 because it is pre-
dicted to target multiple hESC reprogramming factors—OCT4,
SOX2, and KLF4—by TargetScan (Lewis et al., 2003), miRBase
(Griffiths-Jones et al., 2006), and Miranda (Lewis et al., 2005)
(Figure 1C). Thus, miR-145 is a strong candidate repressor of
pluripotency genes.
Ectopic miR-145 Directly Targets OCT4, SOX2,
and KLF4 30 UTR Reporters
To investigate whether OCT4, SOX2, and KLF4 can be directly
targeted by miR-145, we engineered luciferase reporters that
have either the wild-type 30 UTRs of these genes, or the mutant
UTRs with a 6 base pair (bp) deletion in the target sites
(Figure 1D). Reporter constructs such as these are widely used
to provide experimental evidence that miRNAs can directly
repress translation initiation. In HeLa cells, the luciferase
reporters were cotransfected with miRNA precursor (‘‘pre-
miRs’’) mimics, which were processed into mature miRNAs. A
scrambled precursor (‘‘pre-scramble’’) with no homology to the
human genome was used to control the nonspecific effects of
expression. Pre-scramble did not affect the reporter activities.
The pre-miR mimic of miR-145 (‘‘pre-miR-145’’) significantly
reduced the luciferase activities of the wild-type OCT4, SOX2,
and KLF4 reporters between 25%–33% compared to the nega-
tive control pre-scramble (two-tailed Student’s t test, OCT4:
p = 1.93 104;SOX2: p = 0.001;KLF4: p = 1.33 106; Figure 1E).
In contrast, mutant reporters were not repressed by pre-miR-
145, which indicates that the target site directly mediates the
repression (Figure 1E). Furthermore, no reduced activity was
observed with the pre-miR of miR-128 (‘‘pre-miR-128’’). miR-
128 has no target sites in the OCT4 and SOX2 UTRs, but has a
predicted target site in theKLF4UTRbyTargetScan.Additionally,
miR-145 also repressed the OCT4, SOX2, and KLF4 reporters in
293T cells (Figure S4). Taken together, these results show that
miR-145 directly targets OCT4, SOX2, and KLF4 30 UTRs.
Endogenous miR-145 Directly Targets OCT4, SOX2,
and KLF4 30 UTRs in hESCs
We studied the role of endogenous miR-145 in repressing the
OCT4, SOX2, and KLF4 30 UTR reporters in hESCs under self-
renewal conditions. A luciferase reporter with no UTR was
used as a negative control, which is resistant to any miRNA
repression in hESCs. At 24 hr after transfection, there was signifi-
cant repression on the wild-type 30 UTR luciferase reporter
activities of OCT4 (p = 5.1 3 105), SOX2 (p = 1.0 3 105), and
KLF4 (p = 1.2 3 106) in comparison to the no-UTR control,
and these effects persisted at 48 hr (Figures 2A–2C). In contrast,
the mutant reporters with a 6 bp deletion of the miR-145 target
sites had significantly less repression than the wild-type
reporters (OCT4, p = 1.3 3 107; SOX2, p = 0.03; KLF4, p =
0.002. Figures 2A–2C). Particularly, the OCT4 mutant reporter
was indistinguishable from the no-UTR control, which suggests
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Figure 1. The Expression of miR-145 in hESCs and Target Validation of the OCT4, SOX2, and KLF4 30 UTRs
(A) The relative level of miR-145 increased after the hESC differentiation. In Taqman real-time RT-PCR, the snoRNA h-NR003022 was used as an internal
normalization control. EB, embryoid bodies.
(B) The in situ expression of miR-145 RNA in the day 8 differentiated hESCs by EB formation. Red fluorescent signal was from CY3-miR-145 RNA probe, while
blue fluorescent signal was from nuclear DNA counterstained with DAPI. The scale bar represents 50 mm.
(C) Summary of miR-145 target sites in the 30 UTRs of KLF4, POU5F1 (encoding for OCT4), and SOX2. H, human; R, rat; M, mouse; D, dog. The underlined
nucleotides (target sites) were deleted in the mutant 30 UTR constructs.
(D) The 30 UTR reporters in target validation. Luc, firefly luciferase; pA, polyadenylation signal; WT, wild-type. Mutant UTR has a 6 bp deletion of the miR-145
target site.
(E) miR-145 specifically represses its targets in the luciferase assay in HeLa. Relative luciferase level = (Sluc/Srenilla)/(Cluc/Crenilla). Luc, raw firefly luciferase activity;
Renilla, internal transfection control renilla activity; S, sample; C, control pre-scramble. Student’s t test compared two data sets marked by brackets in the panel.
** p < 0.01. The error bar represents the standard deviation (SD) from three independent experiments. +, wild-type; MT, mutant UTRs.that the OCT4 UTR is inhibited solely by miR-145. Unlike OCT4,
SOX2 and KLF4 may be downregulated by other miRNAs
besides miR-145, as evidenced by the continued partial repres-
sion of the mutant reporters. We conclude that the endogenous
miR-145 in hESCs is sufficient to repressOCT4,SOX2, andKLF4
30 UTR reporters directly.
We further addressed the dependence of OCT4, SOX2, and
KLF4 30 UTR reporter repression on the level of miR-145.
Because the difference between the wild-type and mutant
reporters can be attributed to the action of miR-145 alone, the
difference is best reflected by the ratio of the mutant reporter
to the mean of the wild-type reporter (Lewis et al., 2003). Indeed,
the depletion of miR-145 by antisense inhibitor locked nuclei
acid (LNA) in hESCs completely abolished the differential regula-
tion between the mutant and wild-type 30 UTR reporters (Figures
2D–2F), indicating that the repression on the target UTR
reporters was miR-145 dependent.
Next, we studied the repression of theOCT4, SOX2, and KLF4
UTRs by miR-145 during hESC differentiation. Upon withdrawal
of basic fibroblast growth factor (bFGF) in hESC cultures, the
magnitude of repression for the OCT4 and KLF4 UTRs as repre-
sented by the ratio of the mutant to wild-type reporters showeda significant increase as differentiation progressed to day 2, 4,
and 8 (Figures 2G and 2I). Consistent with the repression of the
30 UTRs, OCT4 and KLF4 proteins also showed a gradual
decrease during differentiation (Figure S5A). In contrast, the
wild-type and mutant SOX2 reporters failed to exhibit a signifi-
cant difference after differentiation (Figure 2H). These results
indicate that the endogenous miR-145 exerts more repression
on OCT4 and KLF4 than on SOX2 during hESC differentiation.
The Effect of miR-145 on Endogenous OCT4, KLF4,
and SOX2 in hESCs
miRNAscandownregulategeneexpressionbyeither of twopost-
transcriptional mechanisms: mRNA cleavage or translational
repression (Bartel, 2004). Because luciferase assay does not
distinguish the two mechanisms well, we further examined how
miR-145 repressed the endogenous OCT4, KLF4, and SOX2 in
hESCs. We upregulated miR-145 by expressing the miR-145
precursor from a lentiviral vector (‘‘Lenti-miR-145’’), and studied
the effect on the mRNA and protein levels of these three factors.
Three days after Lenti-miR-145 virus infection, we isolated the
GFP-positive (‘‘GFP+’’) hESC population that expressed the
viral-vector-encoded GFP by fluorescence-activated cell sortingCell 137, 647–658, May 15, 2009 ª2009 Elsevier Inc. 649
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Figure 2. Endogenous miR-145 Represses the 30 UTRs of OCT4, SOX2, and KLF4 in hESCs
(A–C) The relative luciferase level of 30 UTR luciferase reporters of OCT4 (A), SOX2 (B), and KLF4 (C) in hESCs under self-renewal conditions at 24 hr or 48 hr after
transfection. Mut, mutant UTR with a 6 bp deletion of the miR-145 target sites; Control, the basal luciferase reporter without UTR. ** p < 0.01; * p < 0.05. The error
bar represents the standard deviation (SD) from three independent experiments.
(D–F) The difference between 30 UTRmutant and wild-type luciferase reporters of OCT4 (D), SOX2 (E), and KLF4 (F) depends onmiR-145 in hESCs. On the y axis,
the mutant reporter level is normalized against the average of the wild-type reporter level to reflect the magnitude of repression.
(G–I) The repression of OCT4 (G) and KLF4 (I) but not SOX2 (H) UTR reporter by miR-145 increased during hESC differentiation from day 2–8.(FACS) (Figure 3A). To rule out any effect of lentivirus infection,
we used the same lentivector expressing a scrambled sequence
(‘‘Lenti-scr’’) with no homology to the human genome in parallel
as a control. Quantitative real-time RT-PCR revealed that the
mRNA level of SOX2, but not OCT4 or KLF4, was decreased in
the Lenti-miR-145 population compared to the Lenti-scr control
population (Figure 3B). Western blot analysis showed that the
protein levels of OCT4 and KLF4, but not SOX2, were reduced
by Lenti-miR-145 (Figure 3C). These results are in linewith recent
study demonstrating that some targets are repressed without
detectable changes in mRNA levels, while other targets show
mostly mRNA destabilization (Baek et al., 2008). The reduction
of the OCT4, KLF4 protein, and SOX2 mRNA levels indicates
that these endogenous reprogramming factors are posttran-
scriptionally controlled by miR-145 in hESCs.
Next, we investigated whether the endogenous miR-145 in
hESCs is necessary to repress the three factors. We downregu-
lated miR-145 in hESCs by transfection of the Alexa488-conju-650 Cell 137, 647–658, May 15, 2009 ª2009 Elsevier Inc.gated miR-145 antisense inhibitor LNA sequence (‘‘LNA-miR-
145’’), and FACS isolated the Alexa488-positive population at
48 hr (Figure 3D). As a control, a scrambled LNA sequence
(‘‘LNA-scr’’) was used in parallel. In comparison to the LNA-scr
control, the mRNA level of SOX2 and the protein levels of
OCT4, SOX2, and KLF4 were upregulated (Figures 3E and 3F)
when miR-145 was depleted in LNA-miR-145. These findings
are consistent with the capacity of endogenous miR-145 in
hESCs to repress ectopic UTR reporters (Figure 2), and indicate
that endogenous miR-145 constantly modulates the level of its
targets.
miR-145 Upregulation Is Sufficient to Inhibit
hESC Self-Renewal
Next, we studied the functional role of miR-145 in modulating
hESC self-renewal by a gain-of-function approach. As we have
found that miR-145 targets multiple pluripotency factors, we
investigated by analyzing the self-renewal marker SSEA4
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Figure 3. Effect of miR-145 on Endogenous OCT4, KLF4, and SOX2 in hESCs
(A) Isolation of the GFP+ hESCs under self-renewal conditions expressing the control Lenti-scr or Lenti-miR-145 by FACS.
(B and C) Relative mRNA (B) and protein (C) levels of OCT4, SOX2, and KLF4 in control Lenti-scr or Lenti-miR-145 GFP+ cells.
(D) Isolation of the Alexa488-positive hESCs under self-renewal conditions transfected with Alexa488-conjugated LNA-scr control or LNA-miR-145 by FACS.
(E and F) Relative mRNA (E) and protein (F) levels ofOCT4, SOX2, and KLF4 in LNA-scr or LNA-miR-145 transfected cells. In real-time RT-PCR,GAPDHmRNA is
the normalization control (B and E). In western blot (C and F), protein level quantification was normalized to GAPDH.whether the maintenance of self-renewal under normal culturing
conditions would be affected by increased miR-145. In compar-
ison to the negative control Lenti-scr, upregulation of miR-145
throughLenti-miR-145 expression for 6 days caused a significant
drop of the self-renewal marker SSEA4 staining (p = 0.0004,
Figure 4A) in lentiviral GFP-expressing cells analyzed by flow
cytometry. This drop was comparable to that in hESC cultures
deprived of bFGF for 6 days, which suggests that Lenti-miR-
145 is a strong inhibitor of ESC pluripotency. The non-lentivi-
ral-infected GFP-negative cells were unaffected (Figure S6B).
Another self-renewal marker, Tra-1-81 staining, also confirmed
the disruption of hESC maintenance by Lenti-miR-145
(Figure S6A). We also employed a positive control lentivirus
expressing the previously validated OCT4-shRNA (‘‘shOCT4’’)
(Zaehres et al., 2005). The addition of shOCT4 decreased the
self-renewal level significantly, as expected. Furthermore,
Lenti-miR-145 culture also exhibited significantly higher
apoptosis rate compared to the negative control Lenti-scr (p =
0.0002, Figure 4B) assayed by apoptosis marker annexin V
flow cytometry in lentiviral GFP-expressing cells. This suggests
that some cells resorted to apoptosis when they were unable
to self-renew. Another feature of self-renewing hESCs is their
long S phase in the cell cycle. Propidium iodide staining revealed
that Lenti-miR-145 culture had significantly less S phase cells
than Lenti-scr (Figure 4C). These results indicate that the miR-
145 upregulation disrupts the maintenance of the self-renewal
of hESCs, which suggests that miR-145 is a critical negative
regulator of self-renewal.To assess the long-term effect of miR-145, we performed the
colony formation assay. Individual hESCs infected by negative
control Lenti-scr yielded compact and undifferentiated colonies
(Figure 4D) that were all GFP positive, which suggests that the
lenti-vector was stably integrated and highly expressed in these
hESCs. In contrast, hESCs transduced with the Lenti-miR-145
produced small and grossly differentiated colonies (Figure 4D).
Similar effects were observed in the positive control shOCT4
colonies. Quantification of the Lenti-miR-145 phenotypes
showed that the miR-145 inhibited hESC clonogenicity more
than shOCT4 (Figure 4E). At day 11, the Lenti-miR-145 cells
showed a significant drop of self-renewal level compared to
the negative control Lenti-scr (p = 1.4 3 109, Figure 4F).
Furthermore, these Lenti-miR-145 colonies could not be propa-
gated more than one generation under self-renewal culture
conditions, which indicates depletion of stem cells. In summary,
we found that upregulation of miR-145 alone in hESCs is suffi-
cient to prohibit the maintenance of self-renewal, and miR-145
has strong effects probably because of its repression of all three
pluripotency factors together.
miR-145 Promotes Differentiation of hESCs
hESCs can differentiate into cells of extraembryonic trophecto-
derm and three different germ layers: ectoderm, endoderm,
and mesoderm. To assess the effect of miR-145 in modulating
differentiation, we examined the expression of lineage-specific
markers in day 11 Lenti-miR-145 culture and the control Lenti-
scr culture by immunostaining and real-time qRT-PCR. ByCell 137, 647–658, May 15, 2009 ª2009 Elsevier Inc. 651
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Figure 4. Overexpression of miR-145 Inhibits hESC Self-Renewal and Colony Formation
(A) Inhibition of self-renewal during hESCmaintenance by ectopic miR-145 in the Lenti-miR-145-expressing/GFP+ cells. After regular mechanical splitting of the
hESC colonies, the cells were transduced with lentiviruses and maintained under self-renewal conditions for 6 days. Self-renewal is assessed by flow cytometry
analysis of the SSEA4 staining in lentiviral GFP expressing cells (GFP+) cells. Flow cytometry data collection was in two channels: GFP in green channel and
SSEA4 in yellow channel. The self-renewal percentage was N(GFP+SSEA4+) / (N(GFP+ SSEA+) + N(GFP+ SSEA)). N, number of events. t test compared shOCT4 or
Lenti-miR-145 to control Lenti-scr. ** p < 0.01. n = 6.
(B) Increased apoptosis in Lenti-miR-145 cells after 6 days, assessed by flow cytometry analysis of the annexin V staining in lentiviral GFP-expressing (GFP+)
cells. The percentage was N(GFP+Annexin+) / (N(GFP+ Annexin+) + N(GFP+ Annexin)). ** p < 0.01. n = 6.
(C) Decreased S phase population in Lenti-miR-145 GFP+ cells sorted after 6 days. The cell cycle is analyzed by flow cytometry after propidium iodide (PI) stain-
ing, and the data are processed with the ModFit LT program.
(D) Themorphologies of the hESC colonies 11 days after single cell transduction. Left column, bright field images; right column, GFP images. The scale bar repre-
sents 100 mm.
(E) Reduction of hESC colony formation by miR-145. Total, sum of total colony number in three experiments; Differentiation, the differentiated colony number. In
each experiment, 105 single cells were transduced (MOI equaled 20) for 24 hr, and further cultured in fresh conditioned medium with bFGF for 11 days.
(F) Reduction of hESC self-renewal in Lenti-miR-145-expressing/GFP+ cells after 11 days. ** p < 0.01. n = 6.immunostaining, Lenti-miR-145 hESCs displayed a marked
increase of the mesoderm-specific marker a-smooth muscle
actin (SMA, Figure 5A), and the ectoderm-specific marker b-III
tubulin (TUJ1, Figure 5B). The endoderm marker a-fetoprotein
(AFP) showed no signals (Figure 5C). By qRT-PCR, in the pres-
ence of miR-145 upregulation, both the mesoderm marker
MIXL1, NODAL and the ectoderm marker VIMENTIN, OTX2
were upregulated, while the endoderm marker GATA4, FABP1
and the extraembryonic trophectoderm marker CG-a remained
unchanged (Figure 5D). These results demonstrated that
increased miR-145 induced differentiation into the mesoderm
and ectoderm lineages.
We next examined the rate of ESC differentiation in the pres-
ence of miR-145 upregulation. When clusters of hESCs were
differentiated without bFGF, Lenti-miR-145 induced significantly
faster differentiation than the negative control Lenti-scr on day 6
(p = 0.002) and day 12 (p = 0.0003) (Figure 5E). To understand652 Cell 137, 647–658, May 15, 2009 ª2009 Elsevier Inc.whether the miR-145-mediated differentiation is dependent on
depletion of its targets, we introduced expression vectors
without UTRs on differentiation day 6 into the Lenti-miR-145
culture. The lack of 30 UTRsmade these rescue constructs resis-
tant to the regulation by ectopic miR-145. We did not test KLF4
because two other KLF family members, Klf2 and Klf5, are
known to play redundant roles as Klf4 (Jiang et al., 2008), and
their endogenous levels would be sufficient to correct the Klf4
deficiency. After OCT4 and SOX2 expression vectors were intro-
duced together into the Lenti-miR-145 culture, we found that
OCT4 and SOX2 were sufficient to rescue the differentiation
phenotype caused by miR-145 (Figure 5F). In addition, hESC
colony growth and cell death revealed no obvious difference
between control and Lenti-miR-145 (Figures 5G and 5H). Quan-
tification of the colony morphology showed that Lenti-miR-145
produced more differentiation phenotypes (Figure 5I), which
was further supported by alkaline phosphatase staining
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Figure 5. miR-145 Promotes Differentiation of hESCs
(A–C) Increased mesoderm and ectoderm differentiation in Lenti-miR-145 infected hESCs. First column, GFP images; second column, mesoderm marker SMA
(A), ectoderm marker TUJ1 (B), endoderm marker AFP (C).
(D) Relative mRNA level of differentiation marker genesMIXL1,NODAL,GATA4, FABP1, VIMENTIN,OTX2, andCG-a.GAPDHwas used as internal normalization
in SYBR qRT-PCR. ** p < 0.01. n = 6. In (A)–(D), hESC colonies were infected with lentivirus and cultured under self-renewal conditions for 11 days.
(E) Upregulation of miR-145 elevates differentiation rate. Percentage of differentiation = 100% percentage of self-renewal (assayed by SSEA4 expression flow
cytometry). In (E)–(I), hESC colonies were cultured under differentiation conditions without conditioned media and FGF.
(F) Effect of miR-145 on differentiation is mediated by OCT4 and SOX2. Expression of the OCT4/SOX2 rescue constructs completely inhibits the effect of ectopic
miR-145 in promoting differentiation.
(G and H) Lenti-miR-145 has no obvious effect on hESC growth (G) and death (I) during differentiation.
(I) Lenti-miR-145 induces more differentiated colonies on differentiation day 12.(Figure S7). On the basis of all of the results above, we conclude
that miR-145 acts through repression of multiple pluripotency
factors to promote differentiation.
Necessity of miR-145 during hESC Differentiation
Next, we examined the effect of miR-145 loss of function on
differentiation progression. In cells transfected with the inhibitor
LNA-miR-145, the miR-145 level was downregulated (Fig-
ure 6A). In LNA-miR-145 cells, the differentiation rate was sig-
nificantly reduced compared to the LNA-scr control at 48 hr
(p = 0.02) and 96 hr (p = 4.1 3 107) (Figure 6B). To exclude
the possibility that the LNA base modification position has any
effect, two other miR-145 inhibitors were tested, and they
showed similar results (data not shown). Furthermore, the
LNA-miR-145 culture had significantly more S phase cells thandid the LNA-scr control at 48 hr (Figure 6C). Isolation and anal-
ysis of an LNA transfected population under differentiation
conditions demonstrated the derepression of target expression
by inhibition of miR-145 (Figures 6D and 6E) and the deregula-
tion of a panel of differentiation markers representing endoderm
mesoderm and trophectoderm lineages (Figure 6H). The LNA-
miR145 culture also had more alkaline phosphatase staining,
consistent with impairment in differentiation (Figure 6G). In
summary, the disruption of miR-145 upregulation during differ-
entiation leads to direct deregulation of target expression and
indirect disruption of differentiation progression. Thus, miR-
145 is necessary in downregulation of pluripotency genes during
differentiation.
To test the hypothesis that increased OCT4 and SOX2 levels
may mediate the effect of LNA-miR-145, we introduced theCell 137, 647–658, May 15, 2009 ª2009 Elsevier Inc. 653
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Figure 6. Necessity of miR-145 during hESC Differentiation
(A) LNA-miR-145 inhibition decreased the endogenous miR-145 upregulation during differentiation at 48 hr, 96 hr, and 144 hr after transfection compared to
control LNA-scr. The snoRNA h-NR003022 was used as an internal normalization control in qRT-PCR. In Figure 6, hESC colonies were cultured under differen-
tiation conditions without conditioned media and FGF.
(B) miR-145 depletion by LNA-miR-145 delayed hESC differentiation at 48 hr and 96 hr after transfection. Percentage of differentiation = 100%  percentage of
self-renewal (assayed by SSEA4 expression flow cytometry).
(C) miR-145 depletion resulted in increased S phase population during the cell cycle. The cell cycle is analyzed by flow cytometry after PI staining, and the data are
processed with the ModFit LT program.
(D) FACS isolation of the Alexa488-positive hESCs under differentiation conditions transfected with Alexa488-LNA-scr control or LNA-miR-145.
(E) Western blot of Alexa488-LNA sorted hESCs. Protein level quantification was normalized to GAPDH and is provided under each band.
(F) The differences in differentiation between LNA-scr and LNA-miR-145 was rescued by shOCT4 and shSOX2, two vectors that downregulate OCT4 and SOX2.
(G) The alkaline phosphatase staining of hESC differentiation at 96 hr after LNA transfection.
(H) LNA-miR-145 elevated the target gene expression of OCT4, KLF4 and disrupted the expression of differentiation markers.shOCT4 and shSOX2 lentiviruses together into the LNA-miR-145
culture to knockdown the expression of these factors. Indeed,
shOCT4 and shSOX2 reversed the differentiation impairment in
LNA-miR-145 culture (Figure 6F). We conclude that miR-145
acts through the OCT4 and SOX2 pathway to control the
progression of hESC differentiation.
Transcriptional Regulation of miR-145 by OCT4
To understand how endogenous miR-145 is regulated transcrip-
tionally, we analyzed its promoter region in the UCSC genome
browser for cross-species conservation. We found an OCT4654 Cell 137, 647–658, May 15, 2009 ª2009 Elsevier Inc.binding motif (‘‘Site 1’’) within a homologous region 1 kb
upstream of the transcription start site. Because OCT4 showed
a reversed expression pattern from miR-145, we hypothesized
that OCT4 may functionally repress the miR-145 promoter. A
luciferase reporter (‘‘P-miR-145’’) containing a 1.5 kb promoter
sequence showed a 2.7-fold increased expression in HeLa cells
compared to a control vector (‘‘P-control’’) containing a basal
promoter (Figure 7A). However, the P-miR-145 reporter activity
dropped significantly when OCT4 protein was expressed in
increasing amounts (Figure 7A). Such repression was completely
abolished when the promoter deletion (‘‘P-del’’) containing no
A B
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Figure 7. miR-145 Promoter Transcription Is Regulated by OCT4
(A) Ectopic OCT4 repressesmiR-145 promoter transcription in HeLa cells. The promoter construct P-miR-145 contains a putative OCT4 site (‘‘Site 1’’), which was
deleted in P-del. For derivation of the relative luciferase level, the raw luciferase activity was first normalized to the internal transfection control Renilla and then
divided by the average value of the basal construct P-control. Open triangle indicates increasing amounts of OCT4 proteins expressed from a pSin-EF2-Oct4-Pur
vector. n = 3.
(B) EMSA shows the interaction between the miR-145 site 1 and OCT4 in hESCs. NE, nuclear extracts; Ab, antibodies; Ng, negative control NANOG antibody;
Comp, cold competitor probes; Hs27, negative control human fibroblast cells which lack OCT4. Top arrows, shifted probes; bottom arrows, free probes. Lanes 1,
5, 9 and 13 are nuclear extract-free negative controls without any shift.
(C) Chromatin IP shows high OCT4 enrichment at the miR-145 promoter in hESCs, but not in BMP4-differentiated cells (hESC-BMP4). Relative enrichment is
normalized to control IgG. The positions of each PCR amplicon relative to the transcription start site of each promoter are labeled. n = 3.
(D) Proposed model of the double-negative feedback loop by miR-145 and three factors. miR-145 inhibits self-renewal and pluripotency factors OCT4, SOX2,
and KLF4 and controls differentiation. Grey color, low level of either miR-145 or pluripotency factors; bold font, high level of either miR-145 or pluripotency
factors.OCT4 site was tested in parallel. These results suggest that the
1.5 kb sequence upstream of miR-145 has an intrinsic promoter
activity, and such activity is repressed by OCT4.
With an electrophoretic mobility shift assay (EMSA), both a
biotin-miR-145 probe spanning the OCT4 site 1 and a positive
control biotin-NANOG probe spanning a known OCT4 site in
the NANOG promoter produced a significant shift in the hESC
nuclear extract (Figure 7B). This shift was absent in a human
fibroblast cell line Hs27 nuclear extract, which lacked OCT4.
Furthermore, an OCT4 antibody, but not a nonrelevant NANOG
antibody, disrupted the shift, which suggests the specificity of
the interaction. Finally, addition of a NANOG control or cold
competitor probes of miR-145 site 1 also abolished the shift, but
cold miR-145 mutant or nonspecific oligos failed to do so. Thus,
the EMSA assay confirms that themiR-145 promoter contains an
OCT4 binding site and that the interaction is hESC specific.To validate the in vivo interaction between OCT4 and the miR-
145 promoter, we harvested OCT4-bound DNA sequences by
chromatin immunoprecipitation (CHIP) with an OCT4 antibody
and amplified it with PCR primers spanning miR-145 and the
human NANOG promoter. Consistent with a previous report
(Rodda et al., 2005), the positive control NANOG promoter
element (0.1 kb) had significant OCT4 enrichment, while the
negative control region (+0.2 kb) did not (Figure 7C). Remark-
ably, the OCT4 site 1 in the miR-145 promoter and its flanking
sequences also showed high OCT4 enrichment over the immu-
noglobin G (IgG) control. To address the specificity of the
OCT4 interaction on the promoter, we tested whether the
OCT4-bound DNA would be depleted when the OCT4 level is
reduced in differentiating hESCs induced by BMP4 (‘‘hESC-
BMP4’’) (Xu et al., 2002). We found that OCT4 binding to the
miR-145 promoter was completely lost in hESC-BMP4Cell 137, 647–658, May 15, 2009 ª2009 Elsevier Inc. 655
(Figure 7C). These experiments indicate that OCT4 acts as a
transcriptional repressor on miR-145 in hESCs.
DISCUSSION
In summary, we uncovered a direct link between a miRNA and
the core pluripotency factors OCT4, SOX2, and KLF4 (Fig-
ure S8) and demonstrated that miR-145 represses pluripotency
and controls ESC differentiation. The functions of miRNAs in
mammalian development have attracted much attention and
research interest. Recent reports showed that differentiation of
somatic stem cells (Yi et al., 2008) and mouse ESCs (Tay et al.,
2008a; Tay et al., 2008b) can be modulated by miRNAs through
posttranscriptional attenuation of key ESC factors. Here, we
show that in human ESCs a specific miRNA plays a key regula-
tory role by direct targeting of the pluripotency factors OCT4,
SOX2, and KLF4. hESCs require different growth factors and
signaling pathways from mouse ESCs to maintain their self-
renewal (Thomson et al., 1998). From this perspective, it comes
as no surprise that the miR-145 target site in the OCT4 30 UTR is
human specific. Analysis of the evolutionary impact of miRNAs
and experimental validations indicate that many nonconserved
sites mediate repression in vivo (Baek et al., 2008; Farh et al.,
2005). In light of these studies, combining conversed and non-
conserved target prediction will likely provide more insight into
the specific roles of miRNAs for future research.
Although OCT4 and SOX2 are well known for their require-
ment in ESCs, the consequence of elevated OCT4 and SOX2
dosages on ESC self-renewal and pluripotency may have
been largely overlooked. A less than 2-fold increase of Oct4
protein turns murine ESCs into primitive endoderm and meso-
derm, and repression of Oct4 results in trophectoderm (Niwa
et al., 2000). A less than 2-fold increase in Sox2 protein triggers
the ESC differentiation into neuroectoderm, mesoderm, and tro-
phectoderm (Kopp et al., 2008). Both Oct4 and Sox2 may be
transcriptionally activated by themselves, as well as other
factors such as Nanog and FoxD3 (Pei, 2008). It poses a threat
to the ESC identity when these strong positive feedback loops
are not controlled properly and coordinately by negative signals.
The presence of negative regulation by amiRNA provides a solu-
tion to the dosage control problem in hESCs. Our data indicate
that even the low level of endogenous miR-145 in hESCs is
capable of repressing the 30 UTR reporters of OCT4, SOX2,
and KLF4. This result suggests that miR-145 provides epige-
netic modulation on the levels of OCT4, SOX2, and KLF4 in
hESCs, when the copy numbers of their 30 UTRs are in excess.
Other miRNAs may also be involved in the negative regulations
of these 30 UTRs, considering the prediction of many miRNA
target sites in the human OCT4, SOX2, and KLF4 30 UTRs.
Just as this manuscript was in preparation, it was reported
that Nanog, Oct4, and Sox2 coding regions were also targeted
by miRNAs in murine ESCs (Tay et al., 2008a). Our work here
is a beginning toward elucidating the functions of miRNA regu-
lators in counterbalancing the strength of the human ESC tran-
scription circuitry.
Our findings further suggest that miR-145 is a node in
a double-negative feedback regulatory loop that involves
OCT4, SOX2, and KLF4 (Figure 7D). Prior to differentiation, the656 Cell 137, 647–658, May 15, 2009 ª2009 Elsevier Inc.endogenous miR-145 is at a low level because of its promoter
repression by OCT4. This low level of miR-145 is still capable
of targeting 30 UTRs of the endogenous OCT4, SOX2, and
KLF4 (Figures 2 and 3). The coexistence of activation and repres-
sion molecules in balance might provide a proper control on the
dosage of pluripotency factors to maintain the self-renewal
state. Upon differentiation, miR-145 is highly elevated because
of its promoter derepression, andmiR-145 reduces ESC pluripo-
tency to promote differentiation. Thus, mir-145 and OCT4 form
a double-negative feedback loop that switches the hESCs
between self-renewal and differentiation. The next unanswered
question is how this pathway may be reversed when dedifferen-
tiation or reprogramming of somatic cells occurs. Would repro-
gramming factor OCT4 turn off miR-145 expression to allow the
reinitiation of self-renewal? Our study suggests that uncovering
the epigenetic regulation by miRNAs would be one of the next
major steps in the delineation of reprogramming pathways.
The reciprocal interplay between multiple pluripotency factors
and a miRNA reveals a new layer of complexity in the regulatory
network that determines stem cell fates.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Supplemental Data.
Cell Culture
hESCs were cultured according to the WiCell Research Institute instructions
and protocols in the UCSB stem cell lab. In brief, H9 cells (WiCell) were main-
tained on mitomycin C- (Sigma) inactivated human embryonic foreskin fibro-
blast hs27 (ATCC) in hESC culture medium. The feeder-free cultures on matri-
gel (BD Biosciences) were maintained with conditioned medium from hs27 at
24 hr intervals. Routinely, hESCs were passaged by mechanical dissociation
every 6–7 days. Differentiation by forming EB suspension was carried out in
hESC medium without bFGF. Alternative differentiation method of feeder-
free hESCs involved the use of nonconditioned hESC medium deprived of
bFGF. BMP4 differentiation was done with daily dose of 50 ng/ml BMP4
(R&D Systems) in hESC medium without bFGF for 7 days. hESC karyotype
analysis was done by Cell Line Genetics.
Lentiviral Preparation and Transduction in hESCs
Lentivirus production and titering were carried out according to protocols from
Tronolab (http://tronolab.epfl.ch). Two transduction methods, cell cluster
transduction or single-cell suspension transduction, were adapted from previ-
ously described protocols (Gropp and Reubinoff, 2006). For the study of main-
tenance, the hESC colonies were mechanically dissected into small clusters
and plated in 2 ml aliquots per well in 6-well matrigel-coated plates at multi-
plicity of infection (MOI) 20. For the study of colony formation, hESCs colonies
were dissociated into single-cell suspension, pelleted, resuspended in condi-
tioned medium plus 4 ng/ml bFGF (self-renewal condition) at 105 cells per ml,
and plated in 2 ml aliquots in 6-well matrigel-coated plates in the presence of
virus at MOI 20.
RNA Isolation and Real-Time PCR Analysis
RNA was extracted with the miRVana Isolation Kit (Ambion). The miRNA levels
were assayed with the Taqman probes and primer sets in an Applied Bio-
systems PRISM 7900HT Fast Real-Time PCR System (Applied Biosystems)
according to the manufacturer’s instructions. For mRNA analysis, total RNA
were treated with the Turbo DNA-free kit (Ambion), reversed transcribed
with SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen),
and amplified with Power SYBR Green PCRMaster Mix (Applied Biosystems).
GAPDH mRNA level was used as internal normalization control.
Luciferase Reporter Transfection and Dual Luciferase Assay
In 30 UTR assay, 5 3 104 HeLa cells were transfected with 200 ng of the UTR
reporter (pMir-Report), 20 ngof the transfection control Renilla vector (phRLTK,
Promega), and 30 pmol pre-miR miRNA precursor molecules (Ambion; note
that these are not hairpin constructs and should not be confused with pre-
miRNAs) with 3 ml of Lipofectamine 2000. When hESCs were used, the hESCs
were split at 1 to 2 ratio in 24-well plates coated with matrigel. Two hundred
nanograms of the pMIR-Report vector and 20 ng of the transfection control
Renilla vector phRLTK were tranfected with 1.5 ml of Lipofectamine 2000 in
each well.
Lysates were harvested 24 hr or 48 hr after transfection, and reporter activity
was measured with the Dual Luciferase Assay (Promega). In the promoter
activity assay, 83 104 HeLa cells were transfected with 200 ng of the pTrans-
lucent vector, 20 ng of the Renilla control, and 1.5 ml Lipofectamine 2000. The
lysates were processed as described above with the Dual Luciferase Assay
(Promega).
FACS and Flow Cytometry Analysis of Self-Renewal, Apoptosis,
and the Cell Cycle
For isolation of subpopulation of hESCs that expressed GFP from lentiviral
infection, or contained alexa488 conjugated LNA, cells were sorted on BD
FACSAria cell sorter with 100 mm nozzle and according to instructions from
facility instrument technicians.
For self-renewal analysis, each 100 ml of cell suspension (1–5 3 105 cells)
was incubated with the primary antibody mouse anti-SSEA4 (Chemicon) and
PE-conjugated Goat anti-Mouse (Jackson ImmunoResearch). For apoptosis
analysis, 1–5 3 105 cells from each sample were processed with Annexin
V-PE (Annexin V-PE apoptosis detection kit, Biovision) according to the manu-
facturer’s instructions. For cell cycle analysis, 1–5 3 105 cells from each
sample were processed with the Cycletest Plus DNA Reagent Kit (BD Biosci-
ences) staining solution according to the manufacturer’s instructions and
analyzed by the ModFit LT program.
LNA Transfection in hESCs
hESC colonies were grown on matrigel-coated 6-well plates. Fifty nanomolar
LNA (Proligo, Sigma) and 14 ml transfection reagent Lullaby (OZbiosciences)
were used to transfect each well according to the manufacturer’s instructions.
Fluorescent In Situ Hybridization
HESCs were grown on matrigel-coated 6-well plates or chamber slides (Lab-
tech). For the detection of microRNA, LNA probes were labeled with cy3-dUTP
(Amersham) in 30-end labeling reaction (Roche) according to the manufac-
ture’s directions. The slides were hybridized with LNA probes overnight,
washed three times with 50% formamide/23 saline-sodium citrate (SSC)
and three times with 23 SSC at 45C for 5 min each.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and eight
figures and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(09)00252-9.
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